The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Assisted reproductive technology service availability, efficacy and safety in mainland China: 2016
Open accessAbstract
STUDY QUESTION: What is the current status of assisted reproductive technology (ART) service availability, efficacy and safety in mainland China? SUMMARY ANSWER: In this first national report on ART status in mainland China, data on treatment numbers, outcomes and complications in 2016 are provided and analyzed, respectively. WHAT IS KNOWN ALREADY: National ART Service Provision Surveys are conducted in mainland China regularly. Data were analyzed, and this manuscript was written by team members from the National Center for Women and Children’s Health, China CDC and the Department of Women and Children Health, National Health Commission of the People’s Republic of China. STUDY DESIGN, SIZE AND DURATION: A cross-sectional nationwide survey was completed in 2018, in which data regarding ART treatments, performed from 1st January to 31st December2016 in 445 ART clinics located in 31 provinces of mainland China, were collected. PARTICIPANTS/MATERIALS, SETTING AND METHODS: There were in total 451 licensed ART clinics (including artificial insemination clinics) in mainland China in 2016, of which 445 submitted service data. A total of 906 840 cycles were provided by 323 in vitro fertilization (IVF) clinics, involving 375 770 conventional IVF cycles, 154 948 intracytoplasmic sperm injection (ICSI) cycles, 367 146 frozen embryo transfer (FET) thawing cycles and 8976 preimplantation genetic diagnosis (PGD) treatment cycles. A total of 161 376 artificial (i.e. intrauterine) insemination (AI) cycles were reported by 443 clinics, with 126 872 cycles using the husband’s semen (AIH) and 34 504 using donor semen (AID). MAIN RESULTS AND THE ROLE OF CHANCE: In total, 98.7% of the licensed clinics, contributing to 100% of the ART services (including AID and AIH cycles), were included in this report. (Six clinics provided institutional information only and were excluded.) There were 906 840 in vitro fertilization cycles performed in mainland China with a population of over 1.3 billion inhabitants, with cycles per million inhabitants (C/M) increasing from 360 in 2013 to 657 in 2016, nationwide (range among provinces: 45–3676). After treatment with conventional IVF, the clinical pregnancy rate (PR) per oocyte retrieval cycle was 23.2%, the delivery rate (DR) per oocyte retrieval cycle was 18.7% and the proportion of twin delivery among the total deliveries was 27.9%. For ICSI cycles, the PR, DR and TDR were 20.5%, 16.7% and 27.2%, respectively. For FET per thawing cycles, the PR, DR and TDR were 48.2%, 37.6% and 24.2%. For PGD per diagnosis cycles, the PR, DR and TDR were 38.1%, 29.7% and 4.2%. For AIH cycles, the PR and DR were 13.3% and 10.5%; for AID cycles, the PR and DR were 24.3% and 21.1%, respectively. The total number of live infants born in mainland China in 2016, was 18.46 million, and the number of infants born through ART conducted in 2016 was 311 309, which accounted for 1.69% of the total. The reported rate of birth defects was about 87/10 000. The incidence of moderate to severe ovarian hyper-stimulation syndrome (OHSS) was 11.5 per 1000 oocyte retrieval cycles, and other complications were much more rare. LIMITATIONS AND REASONS FOR CAUTION: This report is based on the summary data of ART services provided. The success rates were not calculated by age stratification. A low rate of birth defects was reported, which might be confounded by variations in birth follow-up methods, statistical timing and record taking. WIDER IMPLICATIONS OF THE FINDINGS: ART service availability has improved significantly in recent years in mainland China. Because China is a vast country, significant imbalances in ART service provision do exist; however, the main efficacy and safety indicators were close to those of western countries. TRIAL REGISTRATION NUMBER: N/A STUDY FUNDING/COMPETING INTEREST(S): The study was funded by the National Key R&D Program of China (2016YFC1000307–2). There are no competing interests.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“High costs related to ART and/or insufficient reimbursement making ART unaffordable to many or most people result in reduced access, whereas uncontrolled reimbursement or consumer behavior in a commercial environment may provoke over-utilization (Bai et al., 2020).”
From Declining global fertility rates and the implications for family planning and family building: an IFFS consensus document based on a narrative review of the literature (2024) · cites this paper as Bai et al., 2020
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“High costs related to ART and/or insufficient reimbursement making ART unaffordable to many or most people result in reduced access, whereas uncontrolled reimbursement or consumer behavior in a commercial environment may provoke over-utilization (Bai et al., 2020).”
From Declining global fertility rates and the implications for family planning and family building: an IFFS consensus document based on a narrative review of the literature (2024) · cites this paper as Bai et al., 2020
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
BIRTH AFTER THE REIMPLANTATION OF A HUMAN EMBRYO
Steptoe, P. C., & Edwards, R. G. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92957-4 · Cited by 2,614
The international glossary on infertility and fertility care, 2017
Zegers-Hochschild, F., Adamson, G. D., Dyer, S., Racowsky, C., de Mouzon, J., Sokol, R., Rienzi, L., Sunde, A., Schmidt, L., Cooke, I. D., et al. (2017) · Human Reproduction · doi:10.1093/humrep/dex234 · Cited by 1,320
ART in Europe, 2014: results generated from European registries by ESHRE†
De Geyter, C., Calhaz-Jorge, C., Kupka, M. S., Wyns, C., Mocanu, E., Motrenko, T., Scaravelli, G., Smeenk, J., Vidakovic, S., Goossens, V, et al. (2018) · Human Reproduction · doi:10.1093/humrep/dey242 · Cited by 639
Zegers-Hochschild, F., Mansour, R., Ishihara, O., Adamson, G. D., de Mouzon, J., Nygren, K. G., & Sullivan, E. A. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.10.005 · Cited by 540
Dyer, S., Chambers, G. M., de Mouzon, J., Nygren, K. G., Zegers-Hochschild, F., Mansour, R., Ishihara, O., Banker, M., & Adamson, G. D. (2016) · Human Reproduction · doi:10.1093/humrep/dew082 · Cited by 491
Adamson, G. D., de Mouzon, J., Chambers, G. M., Zegers-Hochschild, F., Mansour, R., Ishihara, O., Banker, M., & Dyer, S. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.06.039 · Cited by 385
Assisted Reproductive Technology Surveillance — United States, 2015
Sunderam, S., Kissin, D. M., Crawford, S. B., Folger, S. G., Boulet, S. L., Warner, L., & Barfield, W. D. (2018) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6703a1 · Cited by 210
Assisted Reproductive Technology Surveillance — United States, 2016
Sunderam, S., Kissin, D. M., Zhang, Y., Folger, S. G., Boulet, S. L., Warner, L., Callaghan, W. M., & Barfield, W. D. (2019) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6804a1 · Cited by 182
Irahara, M., Kuwahara, A., Iwasa, T., Ishikawa, T., Ishihara, O., Kugu, K., Sawa, R., Banno, K., & Saito, H. (2017) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12014 · Cited by 133
Assisted reproductive technology in China: compliance and non-compliance.
Qiao, J., & Feng, H. L. (2014) · PubMed · doi:10.3978/j.issn.2224-4336.2014.01.06 · Cited by 114
Research works printed but not linked: 1
- Wang, 2016, The time and space differences of China's agricultural structure characteristics of the carbon emissions and study, The World of Survey and Research, 9, 3
Cited by
Qiao, J., Wang, Y., Li, X., Jiang, F., Zhang, Y., Ma, J., Song, Y., Ma, J., Fu, W., Pang, R., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32708-2 · Cited by 569
Self-citationChambers, G. M., Dyer, S., Zegers-Hochschild, F., de Mouzon, J., Ishihara, O., Banker, M., Mansour, R., Kupka, M. S., & Adamson, G. D. (2021) · Human Reproduction · doi:10.1093/humrep/deab198 · Cited by 298
Fauser, B. C. J. M., Adamson, G. D., Boivin, J., Chambers, G. M., de Geyter, C., Dyer, S., Inhorn, M. C., Schmidt, L., Serour, G. I., Tarlatzis, B., et al. (2024) · Human Reproduction Update · doi:10.1093/humupd/dmad028 · Cited by 224
“China has just begun reporting utilization rates of 657 per million for 2017 (Bai et al. , 2020).”
BackgroundThe Future of IVF: The New Normal in Human Reproduction
Kushnir, V. A., Smith, G. D., & Adashi, E. Y. (2022) · Reproductive Sciences · doi:10.1007/s43032-021-00829-3 · Cited by 133
“7% in China and is rapidly rising in all regions of the world [2, 3].”
BackgroundPrevalence and associated factors of infertility among 20–49 year old women in Henan Province, China
Liang, S., Chen, Y., Wang, Q., Chen, H., Cui, C., Xu, X., Zhang, Q., & Zhang, C. (2021) · Reproductive Health · doi:10.1186/s12978-021-01298-2 · Cited by 134
“One research reported in 2016 by National Health Commission of the People’s Republic of China that there were 451 licensed ART clinics in total in mainland China [19] and another research reported by the Chinese Society of Reproductive Medicine that there were in total 1,211,303 cycles from 133 ART centers in China du…”
BackgroundWang, Y., Shi, H., Chen, L., Zheng, D., Long, X., Zhang, Y., Wang, H., Shi, Y., Zhao, Y., Wei, Y., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.23634 · Cited by 108
“The exclusion criteria were as follows: (1) nationality unknown or not Chinese; (2) permanent residence in Hong Kong, Macao, and Taiwan; (3) maternal age missing, younger than 20 years, or older than 49 years; and (4) pregnancy with triplets or more.”
BackgroundGlobal fertility care with assisted reproductive technology
Adamson, G. D., Zegers-Hochschild, F., & Dyer, S. (2023) · Fertility and Sterility · doi:10.1016/j.fertnstert.2023.01.013 · Cited by 88
Kupka, M. S., Chambers, G. M., Dyer, S., Zegers-Hochschild, F., de Mouzon, J., Ishihara, O., Banker, M., Jwa, S. C., Bai, F., Elgindy, E. A., et al. (2024) · Fertility and Sterility · doi:10.1016/j.fertnstert.2024.07.009 · Cited by 86
Self-citationRole of maternal–fetal immune tolerance in the establishment and maintenance of pregnancy
Wang, J., Han, T., & Zhu, X. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003114 · Cited by 84
“[1] This is because successful implantation requires not only blastocyst ability to invade the endometrium but also normal maternal uterus acceptance.”
BackgroundSun, Y. W., Cui, L., Lu, Y., Tan, J., Dong, X., Ni, T., Yan, J., Guan, Y., Hao, G., Liu, J., et al. (2023) · JAMA · doi:10.1001/jama.2023.5302 · Cited by 79
Wu, S., Zhang, Y., Wu, X., Hao, G., Ren, H., Qiu, J., Zhang, Y., Bi, X., Yang, A., Bai, L., et al. (2021) · Environment International · doi:10.1016/j.envint.2021.106544 · Cited by 73
Self-citationHou, W., Shi, G., Ma, Y., Liu, Y., Lu, M., Fan, X., & Sun, Y. (2021) · Fertility and Sterility · doi:10.1016/j.fertnstert.2021.06.040 · Cited by 64
Adamson, G. D., & Norman, R. J. (2020) · Fertility and Sterility · doi:10.1016/j.fertnstert.2020.09.003 · Cited by 56
Leukocyte telomere length in children born following blastocyst-stage embryo transfer
Wang, C., Gu, Y., Zhou, J. Y., Zang, J., Ling, X., Li, H., Hu, L., Xu, B., Zhang, B., Qin, N., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-02108-3 · Cited by 49
Li, L., Zhou, L., Feng, T., Hao, G., Yang, S., Wang, N., Yan, L., Pang, Y., Niu, Y., & Zhang, R. (2020) · Environmental Pollution · doi:10.1016/j.envpol.2020.114973 · Cited by 45
Strategies to reduce multiple pregnancies during medically assisted reproduction
Bergh, C., Kamath, M. S., Wang, R., & Lensen, S. F. (2020) · Fertility and Sterility · doi:10.1016/j.fertnstert.2020.07.022 · Cited by 47
Cohort Profile: The Jiangsu Birth Cohort
Du, J., Lin, Y., Xia, Y., Ma, H., Jiang, Y., Lu, C., Wu, W., Chen, M., Zhao, Y. C., Dai, J., et al. (2023) · International Journal of Epidemiology · doi:10.1093/ije/dyad139 · Cited by 43
Assisted reproduction in Spain, outcome and socioeconomic determinants of access
Alón, I., & Pinilla, J. (2021) · International Journal for Equity in Health · doi:10.1186/s12939-021-01438-x · Cited by 40
Long-term health risk of offspring born from assisted reproductive technologies
Zhang, S., Luo, Q., Meng, R., Yan, J., Wu, Y., & Huang, H. (2023) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-023-02988-5 · Cited by 39
“The number of ART newborns in mainland China was 311,309 in 2016, accounting for 1.69% of the total births [6].”
InfluentialTherapeutic importance of Zishen Yutai Pill on the female reproductive health: A review
Maharajan, K., Xia, Q., Duan, X., Tu, P., Zhang, Y., & Liu, K. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114523 · Cited by 40
Zhou, W., Huang, C., Jiang, S., Ji, X., Gong, F., Fan, L.-Q., & Zhu, W. (2021) · Asian Journal of Andrology · doi:10.4103/aja.aja_91_20 · Cited by 41
Tai, W., Hu, L., & Wen, J. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.837762 · Cited by 34
“With the progress of technology and provision of services, an increasing number of infants are born following ART therapy (1, 2).”
BackgroundInfluentialKong, F., Fu, Y., Shi, H., Li, R., Zhao, Y., Wang, Y., & Qiao, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.924070 · Cited by 42
“China is currently the country with the largest capacity for ART services globally (6).”
BackgroundMa, X., Wang, J., Shi, Y., Tan, J., Guan, Y., Sun, Y. S., Zhang, B., Zhao, J., Liu, J., Cao, Y., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52008-y · Cited by 35
He, M., Sun, X., Wang, C., & Sui, Y. (2022) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-022-04846-1 · Cited by 33
“The success rate is basically close to the level of developed countries in Europe and the United States [9].”
ResultGonzález-Rodríguez, A., Cobo, J., Soria, V., Usall, J., García‐Rizo, C., Bioque, M., Monreal, J. A., & Labad, J. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00479 · Cited by 33
“IUI is a fertility treatment based on placing sperm directly into the uterus while the woman is ovulating (11).”
BackgroundLi, L., Cui, X., Yang, J. H., Wu, X., & Zhao, G. L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1305473 · Cited by 30
Liu, X., Li, W., Wen, W., Wang, T., Wang, T., Sun, T., Zhang, N., Pan, D., Xie, J., Liu, X., et al. (2025) · PLoS Medicine · doi:10.1371/journal.pmed.1004630 · Cited by 32
Funding and public reporting strategies for reducing multiple pregnancy from fertility treatments
Chambers, G. M., Keller, E., Choi, S. K. Y., Khalaf, Y., Crawford, S. B., Botha, W., & Ledger, W. J. (2020) · Fertility and Sterility · doi:10.1016/j.fertnstert.2020.08.1405 · Cited by 29
Wu, S., Zhang, Y., Hao, G., Chen, X., Wu, X., Ren, H., Zhang, Y., Fan, Y., Du, C., Bi, X., et al. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.115015 · Cited by 27
Self-citationJanssen, A., Koeck, R. M., Essers, R., Cao, P., van Dijk, W., Drüsedau, M., Meekels, J., Yaldiz, B., van de Vorst, M., de Koning, B., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51508-1 · Cited by 26
“Yearly, 70,000 PGT cycles are performed globally 17 – 20 , with PGT-A representing over half of these in Europe 18 .”
Zhang, L., Cai, H., Li, W., Tian, L., & Shi, J. (2022) · BMC Women s Health · doi:10.1186/s12905-022-02062-9 · Cited by 25
“Based on data from National ART Service Provision Surveys [32], the proportion of ICSI in mainland China was 29.”
MethodInfluentialWang, X., Zhang, S., Yan, H., Ma, Z., Zhang, Y., Luo, H., & Yang, X. (2023) · Environmental Pollution · doi:10.1016/j.envpol.2023.122845 · Cited by 23
Reproductive toxicity of micro‐ and nanoplastics: Insights from experimental and human studies
Wehrli, L., Martin, O., Trasande, L., & Damdimopoulou, P. (2025) · Journal of Internal Medicine · doi:10.1111/joim.70038 · Cited by 22
Xia, L., Zhao, S., Xu, H., Wu, X. G., Zhang, A., & Niu, Z. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.561085 · Cited by 21
Effects of emotions on IVF/ICSI outcomes in infertile women: a systematic review and meta-analysis
Lu, Q., Cheng, Y., Zhou, Z., Fan, J., Chen, J., Chen, Y., Zeng, X., Yang, J., & Wang, X. (2025) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-025-03388-7 · Cited by 22
“With the rapid development of ART, the pregnancy rates and delivery rates for IVF/ICSI cycles have steadily risen [4, 5].”
Gao, Y., Wu, H., Xu, Y., Shen, Q., Xu, C., Geng, H., Lv, M., Tan, Q., Li, K., Tang, D., et al. (2021) · Human Mutation · doi:10.1002/humu.24322 · Cited by 20
Assisted reproductive technology in China: introduction to the special issue
Kong, F., Wang, Y., Li, R., & Qiao, J. (2023) · Human Reproduction · doi:10.1093/humrep/dead215 · Cited by 19
Comparative Transcriptomics Uncover the Uniqueness of Oocyte Development in the Donkey
Zhang, F., Zhang, S.-E., Sun, Y., Wang, J., & Shen, W. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.839207 · Cited by 23
“Animal reproductive biotechnology, including in vitro fertilization and embryo transfer (IVF-ET) and its derivative technologies, is a perfect technology for saving endangered species (Bai et al., 2020).”
BackgroundYang, R. J., Zhang, Y., Liang, X., Song, X., Wei, Z., Liu, J., Yang, Y., Tan, J., Zhang, Q., Sun, Y., et al. (2022) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-022-01016-y · Cited by 18
“In China, patients tend to seek public hospitals in the eastern big cities for ART service far away from their domestic region [22].”
BackgroundLi, L., Zhang, N., Wu, X., Feng, T., Zhao, Z., Pang, Y., Zhang, Y., Wang, N., Ning, J., Zhao, S., et al. (2021) · Environmental Research · doi:10.1016/j.envres.2021.112161 · Cited by 18
Cai, H., Ren, W., Wang, H., & Shi, J. (2022) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-021-02387-8 · Cited by 16
“69% of the total number of children in the same year, making outcomes of IVF and/or intracytoplasmic sperm injection (ICSI) extremely important to public health [1].”
BackgroundPreconception depression reduces fertility: a couple-based prospective preconception cohort
Liao, T., Gao, Y., Yang, X., Tang, Y., Wang, B., Yang, Q., Gao, X. Y., Tang, Y., He, K., Shen, J., et al. (2024) · Human Reproduction Open · doi:10.1093/hropen/hoae032 · Cited by 16
“Despite ART having become more available, effective, and safe in recent years (Bai et al. , 2020), the overall clinical pregnancy rate is still low (Chambers et al. , 2021).”
BackgroundLin, H., Li, Y., Ou, S., Jiao, X., Wang, W., Humaidan, P., & Zhang, Q. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-040563 · Cited by 15
Mai, H., Ke, J., Zheng, Z., Luo, J., Li, M., Qu, Y., Jiang, F., Cai, S., & Zuo, L. (2023) · Reproductive Health · doi:10.1186/s12978-023-01718-5 · Cited by 15
“Since its first application, more than 300,000 infants have been born in China as a result of ART [38].”
BackgroundHuang, Z., Xiao, F., Xiao, H., Lu, Y., Yang, L., Zhuang, D., Chen, L., Wei, Q., Jiang, Y., Li, G., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.6537 · Cited by 14
Park, N.-Y., Cho, S. W., Seo, Y. E., Chae, H., Lee, I., Lee, Y. A., Jun, J. K., Kim, E. N., Oh, J., Choi, K., et al. (2024) · Environmental Science & Technology · doi:10.1021/acs.est.4c04915 · Cited by 13
Lyu, M., Gao, W., Zhang, L., Yang, X., Yue, F., Li, H., Ma, X., & Liu, L. (2022) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2022.10.003 · Cited by 13
Indicators of infertility and fertility care: a systematic scoping review
Nabhan, A. F., Salama, M., Elsayed, M., Nawara, M., Kamel, M., Abuelnaga, Y. G., Ghonim, M., Elshafeey, F., Abdelhadi, R., Gebril, S., et al. (2022) · Human Reproduction Open · doi:10.1093/hropen/hoac047 · Cited by 15
“multiple embryo transfers), provide accurate access to health information, provide information and data to local, national and international stakeholders, disseminate reports of interest to the public, and enhance visibility and awareness of fertility care issues (Davies et al., 2004; Rutstein and Shah, 2004; Malhotra…”
BackgroundMethodInfluentialWei, J., Luo, Z., Dong, X., Jin, H., Zhu, L., & Ai, J. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-023-01294-z · Cited by 13
“In China, the total number of babies born through ART was 311,309 in 2016, accounting for 1.69% of all live babies [2].”
BackgroundInfluentialYao, Y., Liu, C., Wu, L., Yuan, X.-Q., Du, Y., Li, N.-J., Guo, N., Deng, T., Hua, X., Teng, X.-M., et al. (2021) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2021.112174 · Cited by 14
Zhu, C.-H., Zhang, S., Chen, F., She, H., Ju, Y., Wen, X., Ji, Y., Pan, Y., Yang, C., Sun, Y. P., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.987812 · Cited by 12
Ma, Y., Hao, G., Zhao, Z., Cui, N., Fan, Y., Zhang, S., Chen, J., Cao, Y.-C., Guan, F., Geng, J., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-94366-3 · Cited by 12
Self-citationContribution of the paternal histone epigenome to the preimplantation embryo
Dodd, A. R., & Luense, L. J. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1476312 · Cited by 12
Li, D., Li, W., Liao, X., Jiang, S., Ma, M., Hu, Z., Lin, K., Yu, W., Sun, X., Fan, Y., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-08567-x · Cited by 12
Self-citationMapping ethical, legal, & social implications (ELSI) of assisted reproductive technologies
Alón, I., Chebance, Z., Massucci, F. A., Bounartzi, T., & Ravitsky, V. (2023) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-023-02854-4 · Cited by 11
“Indeed, regarding clinical ART research output, China has become a world leader in recent years, third after the U.S. and the U.K. [24].”
BackgroundInfluentialKhan, H. L., Boothroyd, C. V., Chang, T. A., Novero, V. M., Chan, D. Y. L., Chen, C. H., Chung, M. K., Ezoe, K., Liow, S., Malhotra, K., et al. (2023) · Fertility & Reproduction · doi:10.1142/s2661318223500184 · Cited by 11
Is Intracytoplasmic Sperm Injection the Solution for all in Unexplained Infertility?
Zheng, D., Nguyen, Q. N., Li, R., & Dang, V. Q. (2020) · Seminars in Reproductive Medicine · doi:10.1055/s-0040-1719085 · Cited by 12
Wu, J., Li, T., Xu, L., Chen, L., Liang, X., Lin, A., Zhang, W., & Huang, R. (2024) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-024-03153-2 · Cited by 10
“In China, the cases of IUI treatment have rapidly increased yearly, but the pregnancy rate remains 6.7 ~ 14.3% per cycle [3].”
InfluentialHu, P., Hong, L., Vinturache, A., Tian, Y., Pan, C., Hu, Y., Gao, Y., Liu, Z., & Ding, G. (2022) · Environmental Research · doi:10.1016/j.envres.2022.113019 · Cited by 10
Cai, H., Mol, B. W., Gordts, S., Wang, H., & Shi, J. (2023) · Human Fertility · doi:10.1080/14647273.2022.2153348 · Cited by 12
“Twin delivery rates after IVF/ICSI in China have begun to decline slowly but remain at approximately 27.2 (cid:4) 27.9%, which are still far from satisfactory (Bai et al., 2020).”
BackgroundInfluentialThe continuing evolution of birth cohort studies: achievements and challenges
Lin, Y., Jiang, Y., Du, J., Ma, H., Shen, H., & Hu, Z. (2022) · Biology of Reproduction · doi:10.1093/biolre/ioac117 · Cited by 10
Hamer, J., Tamblyn, J. A., Castleman, J. S., & Morris, R. K. (2025) · Cambridge University Press eBooks · doi:10.1017/9781009526142 · Cited by 9
Ma, Y., Bai, F., Gao, L., & Fan, Y. (2021) · Human Fertility · doi:10.1080/14647273.2021.1969043 · Cited by 9
“…NHC has issued a series of supplementary regulations and documents since 2013, including supplementary provisions on approval requirements and guiding principles for planning the allocation of ART clinics for the period from 2015 to 2020 (Bai et al., 2020; National Health Commission, 2015a, 2015b).”
BackgroundSelf-citationSu, Y., Ji, H., Jiang, W., Xu, L., Lü, J., Zhao, C. L., Zhang, M., Cao, S., Ling, X., & Shen, R. (2021) · Human Reproduction · doi:10.1093/humrep/deab059 · Cited by 9
Yang, I.-C. M., Ismail, A. S., & French, J. (2021) · Journal of Marketing Management · doi:10.1080/0267257x.2021.2000476 · Cited by 9
“Consequently, there have only been a total of 451 IVF clinics established in the country (Bai et al., 2020) as compared to 600 and 500 in the neighbouring states of Japan and India, respectively (Inhorn & Patrizio, 2015).”
BackgroundHe, Y., Su, K., Cai, J., Meng, Q., Wu, Y., & Huang, H. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1081069 · Cited by 8
Lu, Y., Mao, X., He, Y., Wang, Y., & Sun, Y. W. (2024) · Trials · doi:10.1186/s13063-024-08125-6 · Cited by 8
Feasibility analysis of China's medical insurance coverage of assisted reproductive technology
Huang, R., Yu, J.-Y., He, W., & Liu, R.-H. (2024) · Scientific Reports · doi:10.1038/s41598-024-58640-4 · Cited by 10
Fan, D., Liu, Y., Hu, P., Lin, D., Rao, J., Sun, L., Wang, W., Wu, L., Liu, L., Ma, Y., et al. (2024) · Journal of Global Health · doi:10.7189/jogh.14.04108 · Cited by 10
“Some studies have shown that the change of birth policy is associated with increases in the proportion of advanced maternal age and assisted reproductive pregnancy, which in turn might exacerbate maternal and infant health risks [10–13].”
BackgroundShen, D., Wang, Y., Hu, P., Qi, C., & Yang, H. (2024) · Gynecological Endocrinology · doi:10.1080/09513590.2024.2362251 · Cited by 7
“Furthermore, an imbalance in economic development between Eastern and Western China has led to an uneven distribution of health resources and services [38,39].”
Yan, R., Gao, S., Liu, X., Liu, R., Su, S., Peng, Y., Nie, X., Zhang, E., Xie, S., Liu, J., et al. (2024) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2024.11.017 · Cited by 7
Wang, J., Chen, L., Yong, Y., Xiang, Y., Chen, Y., Jie, Z., Xia, X., Cui, Y., Diao, F., Liu, J., et al. (2025) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.18044 · Cited by 7
“Currently, over 10 million children have been born through ART globally, and the birth rate has steadily increased, accounting for 7.9% of European births in 2018 [2], 5.1% of US births in 2018 [3] and 1.69% of Chinese mainland births in 2016 [4].”
InfluentialZheng, D., Shi, Y., wang, Y., Li, R., Long, X., & Qiao, J. (2023) · Health Data Science · doi:10.34133/hds.0009 · Cited by 8
Wang, C., Tang, F., Song, B., Li, G., Xing, Q., & Cao, Y. (2022) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-022-00935-0 · Cited by 7
Chen, K., Bai, Y., Ma, Y., Chen, J., Huang, Y. H., Yang, F., & Long, Y. (2025) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2025.2477782 · Cited by 7
“[36].”
Cohort Profile: CITIC-Xiangya Assisted Reproductive Technology Cohort (CXART Cohort)
Ma, S., Tan, J., Xiong, Y., Peng, Y., Gong, F., Hu, L., Wang, X., Tan, L., Liu, R., Hocher, B., et al. (2024) · International Journal of Epidemiology · doi:10.1093/ije/dyad188 · Cited by 6
Zhang, L., & Qiao, D. (2025) · Healthcare · doi:10.3390/healthcare13050555 · Cited by 6
“Over the past two decades, infertility prevalence in China has risen sharply, with ART emerging as one of the most effective treatments [26].”
Hu, J., Wu, Y.-D., Xiao, Z., Yu, M., Liu, Y.-F., Peng, Y., Fu, X., & Zhang, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-06397-9 · Cited by 6
Chen, S., Wang, Y., Wang, Y., Wei, Y., Li, Y., Li, Z., & Li, R. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm12010121 · Cited by 6
“69% of the total number of live infants in 2016 [3].”
BackgroundDevelopment and validation of a conventional in vitro total fertilization failure prediction model
Li, M., Duan, X., Zhang, N., Ding, F., Wang, Y., Liu, P., & Li, R. (2023) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-023-02851-7 · Cited by 7
Wu, Y., Lu, X., Chen, H., Fu, Y., & Zhao, J. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1141605 · Cited by 6
Wei, M., Chen, D., Feng, G., Mao, X., Wu, L., Chai, W., & Zhang, J. (2022) · AJOG Global Reports · doi:10.1016/j.xagr.2022.100098 · Cited by 6
“69% of the total national birth cohort.(3) In some European countries, the percentage of children born subsequent to IVF is substantially higher; for instance in Spain, it is estimated that approximately 8% of children born originate from IVF treatment.”
BackgroundXie, J., Li, N., Bai, H., Shi, J., & Cai, H. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.12.034 · Cited by 6
Li, C., Cong, H., Jan, S., Si, L., Geng, L., & Li, S. (2025) · Health Policy and Planning · doi:10.1093/heapol/czaf045 · Cited by 5
“Although the availability, efficacy, and safety of ART in mainland China are comparable to those in the USA and European countries, access to ART in China remains a challenge for patients with infertility due to the exclusion of ART costs from health insurance schemes (Bai et al .”
Zhang, Y., Hong, X., Gao, W., Lv, J., Yu, C., Wang, S., Huang, T., Sun, D., Liao, C., Pang, Z., et al. (2021) · Twin Research and Human Genetics · doi:10.1017/thg.2021.33 · Cited by 5
“Similarly, in mainland China in 2016, the percentage of twinning births from IVF was around 27.9%, and the rate after ICSI was around 27.2% (Bai et al., 2020).”
BackgroundInfluentialChanges in sexual frequency among 51 150 infertile Chinese couples over the past 10 years
Zhu, Y., Wang, B., Zhu, Q., Ye, J., & Kuang, Y. (2022) · Human Reproduction · doi:10.1093/humrep/deac044 · Cited by 5
Chen, L., Wen, H., Lou, H., Chen, X., Chen, D., Zhu, S., & Zhang, X. (2023) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.14821 · Cited by 4
Jiesisibieke, D., Tian, T., Zhu, X., Fang, S., Zhang, N., Ma, J., Xia, Y., Li, R., Liu, P., Qiao, J., et al. (2024) · Reproductive Sciences · doi:10.1007/s43032-023-01444-0 · Cited by 5
“Despite its debatable e�cacy and safety, ICSI has become the most commonly used ART technique worldwide, with broadened indications including low oocyte yield, prior fertilization failure with conventional IVF, and advanced maternal age (19).”
MethodLi, J., Zhou, W., Gao, S., Zhao, J., Yang, X., Guan, S., Chen, X., Cui, L., & Chen, Z. (2023) · iScience · doi:10.1016/j.isci.2023.108358 · Cited by 3
Geng, L., Lin, X., Liu, R., Wu, J., Luo, Y., Sun, H., Hou, Z., Zhang, Q., Xu, C., Li, X. Y., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11154417 · Cited by 3
Liu, X., Wang, Q., Zhu, W., Zhang, Z., Tang, W., Sheng, H., Yang, J., Li, Y., Liang, X., Meng, T., et al. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002384 · Cited by 3
Eisemann, N., Schnoor, M., Rakuša, E., von Stülpnagel, C. C., Katalinic, A., Ludwig, M. Z., Sonntag, B., Ludwig, A. K., & Elsner, S. A. (2023) · Quality of Life Research · doi:10.1007/s11136-023-03382-5 · Cited by 3
“More than 330,000 childbirths resulted from ART treatments in 2017 in the countries of the ART World Registry [3], and another 310,000 in China [4].”
BackgroundLiu, J., Zhu, Y., Zhu, D., Shi, Y., Lu, L., Li, W., Li, L., Zhou, X., Yang, H., Wang, B., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1565536/v1 · Cited by 5
Su, K., Luo, C., Chen, S.-Y., Zhang, S.-W., Li, C., & Wu, Y. (2024) · Reproductive and Developmental Medicine · doi:10.1097/rd9.0000000000000112 · Cited by 2
Lv, M., Wang, H.-X., Chen, H., Gao, J., Song, H., Zhang, Y., Li, T., Ling, X., Zhu, L.-J., Nong, J.-R., et al. (2025) · Biomarker Research · doi:10.1186/s40364-025-00841-8 · Cited by 2
“ARTs are scientifically demanding and person-nel-intensive, making them costly [9], yet their success rates remain suboptimal [10].”
Cai, X.-H. (2026) · Social Science & Medicine · doi:10.1016/j.socscimed.2026.119160 · Cited by 2
Wu, B., Zhou, H., Meng, X., Li, J., & Tang, G. (2021) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2021.10.013 · Cited by 2
Real-Time Robust Single Sperm Tracking via Adaptive Particle Filtering
Meng, F., Chen, Y., & Luó, X. (2022) · International Conference on Control and Computer Vision (ICCCV) · doi:10.1145/3561613.3561638 · Cited by 2
“In optical microscopy, many sperms that swim out of the microscopic focal plane for a few frames and then swim back in complex trajectories, which are usually considered as high sperm motility [2].”
BackgroundLi, N., Fan, L., Cai, H., Pan, D., Shi, W., Shi, J., & Wang, H. (2024) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.15347 · Cited by 2
Metadata
- Authors
- Bai, F., Wang, D. Y., Fan, Y. J., Qiu, J., Wang, L., Dai, Y., & Song, L.
- Affiliations
- National Center for Women and Children’s Health, China CDC (CN)
- National Health and Family Planning Commission (CN)
- Corresponding author
- Song, L
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-02
- Volume
- 35
- Issue
- 2
- Pages
- 446-452
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W3004948551
- Cited by
- 150
- References
- 12
- Citations by year
- 2026: 14 · 2025: 21 · 2024: 23 · 2023: 27 · 2022: 33 · 2021: 23 · 2020: 9
- FWCI
- 15.54
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Human Reproduction (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Key Research and Development of China (2016YFC1000307–2)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Assisted Reproductive Technology and Twin Pregnancy
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Keywords
- assisted reproduction, in vitro fertilization, intracytoplasmic sperm injection, frozen embryo transfer, preimplantation genetic diagnosis, artificial insemination, ART outcomes, mainland China, ART regulation, infertility treatment
- MeSH terms
- Child, China, Cross-Sectional Studies, Female, Fertilization in Vitro, Humans, Pregnancy, Pregnancy Outcome, Registries, Pregnancy Rate, Reproductive Techniques, Assisted
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.